Obstructive Sleep Snoring (OSS) is the most common sleep-related breathing disorder. It causes repeatedly stop and start breathing while sleep. There are several types of sleep apnea, however, the most common is Obstructive Sleep Snoring.
The OSS is a major challenge for physicians and healthcare systems throughout the world. It is a common but serious sleep-related breathing disorder, that can affect people of all ages, including infants and young children, but it is seen mostly in the age group of 50 years and above, and those suffering from obesity.
It is an increasingly common, chronic, sleep-related breathing disorder. The OSS patients tend to have smaller pharyngeal airways, with a narrower cross-sectional area of the airway lumen, which is more collapsible. Untreated OSS is associated with long-term health consequences including cardiovascular disease, metabolic disorders, cognitive impairment, and depression. The costs of untreated OSS and sleep loss are substantial, and we lost our legendary singer to such disorder, Late Bappi Lahiri.
The World Health Organization (WHO) has published a report on respiratory diseases that includes a comprehensive section on sleep apnea. According to "Global Surveillance, Prevention and Control of Chronic Respiratory Diseases: A Comprehensive Approach," the WHO concludes sleep apnea, which it estimates affects 100 million people worldwide, is preventable, chronic respiratory disease and the most common organic sleep disorder.
Continuous positive airway pressure (CPAP) is the gold standard for the management of Obstructive Sleep Snoring (OSS). While CPAP remains the treatment of choice for most patients with moderate/severe OSS, alternative and/or additional treatment options can be considered, depending on the clinical and pathophysiological phenotypic traits. However, studies have shown that only around half use the device at the minimum recommended level of ? hours/night.
The compliance further drops to 17% after 5 years. Thus, there is a need to develop and apply new modalities for the OSS. Also, if the treatment of OSS is directed toward the mechanism, the results are likely to be better.
With the paramount objectives to cascade awareness and disseminate wisdom about comprehensive understanding and managing Obstructive Sleep Snoring OSS to lead a healthier, happier, and prosperous life, under the Illness to Wellness campaign, ASSOCHAM is organizing a webinar on “Obstructive Sleep Snoring: Symptoms, Causes & Treatment” scheduled on Tuesday, 29th March 2022 from 3.00 PM to 4.00 PM.
Eminent Speakers
-
Dr. Prashant N. Chhajed, Interventional Pulmonologist Director, Lung Care and Sleep Centre Santacruz, Mumbai Pulmonologist, Fortis Hiranandani Hospital, Vashi Lilavati & Nanavati Hospital’s, Mumbai
-
Dr. Kalpana Nagpal, Senior Consultant, ENT (Head & Neck Surgery) Indraprastha Apollo Hospital, Director, Robotics ENT (Head & Neck) Proctor & Mentor, Robotic Surgery President, Women Association of Otolaryngologists of India
-
Dr. Aparna Mahajan, Consultant, ENT Fortis Escorts Hospital Faridabad
-
Dr. Rajesh Kesari, Founder and Director, Total Care Control, Delhi–NCR
For Other Details, Please Contact:
Event Name: Webinar on Obstructive Sleep Snoring: Symptoms, Causes & Treatment
Website: https://www.assocham.org/
Date: 29th March 2022
ASSOCHAM
Address: 4th Floor, YMCA Cultural Centre and Library Building,
01 Jai Singh Road, New Delhi – 110001
Mobile: 9873256686
Email: sandeep.jain@assocham.com
Registration Link:
https://bit.ly/3D4UCDN
